Komori
Takara Bio (4974) · InitiativeFirst stated

Restructuring the Next-Generation Sequencing Library Preparation Instrument Business

First written in FY2021-Q2. . Latest entry: FY2021-Q2.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Wind-down and Impairment of the Next-Generation Sequencing Library Preparation Equipment BusinessA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2021-Q2First statedAnnual report

    「The Group recorded extraordinary losses in connection with the rationalization of its next-generation sequencing library preparation instrument business. The main components were an impairment loss of ¥365 million and an inventory valuation loss of ¥98 million.」

    First disclosed the rationalization of the next-generation sequencing library preparation instrument business and recorded an impairment loss of ¥365 million and an inventory valuation loss of ¥98 million.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Takara Bio yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.